Disc-Shaped Microcarrier Market

Key data points: Market size in 2027 = $84.1 million and 2035 = $146.5 million, growth forecast = 7.5% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in disc-shaped microcarrier market to 2035 by type (double-layer and triple-layer), application (cell therapy, vaccine production, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World) Disc-Shaped Microcarrier Market The future of the global disc-shaped microcarrier market looks promising with opportunities in the cell therapy and vaccine production markets. The global disc-shaped microcarrier market is expected to reach an estimated $146.5 million by 2035 from $84.1 million in 2027 with a CAGR of 7.5% from 2027 to 2035. The major drivers for this market are the increasing demand for large scale cell culture, the rising adoption in biopharmaceutical manufacturing processes, and the growing focus on high density cell expansion. • Lucintel forecasts that, within the type category, double-layer is expected to witness higher growth over the forecast period due to more cell attachment surface area of double-layer microcarriers. • Within the application category, vaccine production is expected to witness higher growth over the forecast period due to increased production of cell culture and vaccine productions. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increasing demand for biological drugs and vaccines. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Disc-Shaped Microcarrier Market In the years 2025-2027, the market for disc-shaped microcarriers will be dominated by large-scale cell culture for the manufacture of regenerative medicinal products and biologics. Lucintel’s predictions are aligned with investors’ interests. Discs-shaped microcarriers would enable the generation of higher cell yields and facilitate process reproducibility and automation. • Bioprocess Scalability: Discs-shaped microcarriers enable large-scale bioprocessing and, in combination with stirred-tank reactors, allow the production of thousands of cm² of cellular surface area per bioreactor. • Surface Functionalization: Through 2025, academia focuses on the functionalization of microcarriers with biomolecules to facilitate cellular adhesion. • Closed Processing: In combination with process automation, closed systems facilitate reproducible manufacturing and process automation. • Demand for Regenerative Medicine: 2024 saw more than 500 global clinical trials for cell therapies. Developers work on programs for mesenchymal stem cells and organoids, and clinical trials use chondrocytes. 2030 is expected to have a continued need for large-scale adherent cell cultures for the production of cell therapies. • Need for Manufacturing Improvements: 2025 has manufacturers reviewing their single use processes and evaluating raw materials for their impact on the environment. Regional bioprocessing facilities increased in North America, Europe and Asia. Supply and demand agreements will be signed based on the impact the manufacturer has on the environment and the supply of equipment for sterilization. While the market is expected to grow, several barriers remain. The vendors that offer the broadest range of cell recovery technologies, and services to facilitate and alleviate the challenges of manufacturing, will succeed. Verifying the suitability of the technology for different cell lines will accelerate the qualification process. Vendors that build and develop regional cell and tissue banks will establish long term partnerships. Recent Developments in the Disc-Shaped Microcarrier Market The Microcarrier market based on cell culture is expanding into larger bioprocessing markets. The most significant growth will occur between 2025 and 2027 with advancements in the manufacture of cell and gene therapies and other regenerative medicine. Lucintel expects and can prepare to meet the demand for more advanced microcarriers. • Preparing for Growth: A bioprocessing supplier dedicated more than 2,000 m2 of single-use capacity for microcarrier production in January 2025. The expanded capacity will increase the supplier’s dependable supply of microcarriers in the region. • Process Validation: In April 2025, a cell therapist and a bioreactor supplier agreed to evaluate the expansion of cell therapies using microcarriers at a 50-liter process. Increasing collaborations to validate processes for commercialization will speed up the adoption of bioprocessing for therapies. • Advanced Microcarrier Coating and Cell Attachment Solutions: A supplier began offering a disc-shaped microcarrier with three coating options. While all microcarriers facilitate attachment of cells to culture surfaces, certain cell types can adhere to the microcarrier itself. To reduce shedding for these cells, the supplier claims that more control over the coating and removal of the microcarriers from the culture would alleviate these issues. • Standardization of Microcarrier Characterization: A consortium of companies operating in the cell and gene therapy sector standardized 12 criteria for the characterization of microcarriers. Standardization is expected to facilitate the qualification of microcarriers for highly regulated processes. • Automation of Large-Scale Cell Harvesting: A equipment manufacturer of bioreactor systems demonstrated harvesting from a 200L stirred tank bioreactor. Automation can reduce batch-to-batch variability and decrease total cost of a batch of cells. There is an emerging interest in microcarriers that provide improved surface area to volume ratio while maintaining a stirred-tank-based continuous cell culture. Barriers to commercialization of these microcarriers include consistent and scalable surface modification and low extractables. We expect increased use in cell therapy process development, with subsequent use in development of vaccines and other cell-cultured products. Strategic Growth Opportunities in the Disc-Shaped Microcarrier Market The market for disc-shaped microcarriers is poised for significant growth with the recent interest in the production of cell and gene therapies. From 2024 to 2026, the cell and gene therapy markets are expected to rapidly evolve, presenting new opportunities for producers to address unmet demand. According to Lucintel, there is potential to meet the needs of the cell and gene therapy markets as well as other markets by utilizing microcarriers in ways that improve the efficiency and reduce costs of producing cell therapy products. • Cell Therapy: There is potential to use disc-shaped microcarriers in the production of mesenchymal stem cells and derivatives thereof. • Vaccine and Other Viral Vector Production: There is opportunity to produce different viral vectors by utilizing microcarriers to culture adherent cells. • Higher Prices for Modified Polymer Products: Coatings for polymer products to enhance cell adhesion are in high demand in the biotech and life sciences industries. In September 2025, one company reported that surface modification of their polymer products improved cell adhesion by 30% and is expected to further improve with advancements in the technology. • Increased Focus on Asia: Investments in biomanufacturing in the Asia-Pacific region have created a demand for locally sourced single use products and services as well as support for regulatory approval. In April 2025, Singapore committed S$1 billion to biomedical manufacturing. Rapid advancements in biomanufacturing in the region will increase demand for single use products in China, India, South Korea and other countries in Southeast Asia. • Eco-Friendly Microcarriers: Single use microcarriers manufactured from biodegradable polymers would improve the environmental impact of the product and reduce the cost of microcarrier disposal. Pharmaceutical companies are likely to prefer suppliers of single use microcarriers based on sustainability in the long term. The products with the greatest potential are those that facilitate large scale cell-based manufacturing and provide evidence that supports consistent and reliable cell recovery and transfer. There is significant opportunity in the cell based manufacturing industry and demand will continue to increase as more companies utilize this technology. Disc-Shaped Microcarrier Market Drivers and Challenges Innovations in bioprocess technologies and automation coupled with demand for large-scale cell expansion to cater to the growing need for bio-pharmaceuticals has created a strong market potential for disc-shaped microcarriers. The regulatory environment also favors the cell culture industry and encourages use of sustainable practices. The factors responsible for driving this market include : • Increased Use of Cell Therapies: Discs-shaped microcarriers allow for high-efficiency and large-scale culture of cells in three-dimensional formats that are required for the development of therapeutic products derived from stem cells, among others. The number of active clinical studies for cell therapies worldwide has been increasing. As of January 2025, about 1,500 such studies were being conducted. Moving forward, disc-shaped microcarriers should find increased use within the biopharmaceutical industry and contract services, especially in the next 3-5 years. • Advancements in polymer and coatings technology, in addition to advancements in other related technologies, help improve the attachment and recovery of cells grown in bioreactors. In April 2025, one research article stated that the optimization of the coating of microcarriers improved the maximum cell adhesion by 30%. The focus of the research studies has been improving the cultivation of primary cells and stem cells. During the next 3-5 years, it is expected that the automation of microcarrier-based processes will allow for the establishment of large-scale manufacturing of biologics. • Regulatory agencies promote the development and characterization of advanced manufacturing platforms. In February 2025, regulatory agencies published guidance focusing on the characterization and comparability of cell-based products. The use of disc-shaped microcarriers facilitates closed and continuous processing. Over the next 3-5 years, it is expected that similar guidance will be issued in other regions and it is likely that the focus of the guidance will be on advanced and integrated manufacturing systems. • The focus of the biopharmaceutical industry has been on reduction in the consumption of processing resources and by-products. In June 2025, one bioreactor manufacturer stated that by optimizing the feeding of microcarriers, a 20% reduction in the volume of medium required to culture cells could be achieved. It is expected that within the next 3-5 years, especially in the context of larger manufacturers focusing on reducing their carbon footprint, improvements in microcarrier technology will allow for a reduction in the volume of processing resources consumed. • Improvements in Efficiency and Cost Savings: The use of microcarriers in suspension-based cell culture provides advantages over planar cell culture systems, particularly in terms of scale. Data from September 2025 showed that automated systems for microcarrier-based cell culture reduced labor time by 25%. The use of single-use bioreactors and standardized methods for the downstream process further improve labor and increase process consistency. Advantages in cost and throughput of this technology are expected to result in its rapid adoption in commercial cell culture, especially in applications requiring large-scale and repeated expansions of cell culture. The challenges facing this market include: • Biological Variability and Process Complexity: The microenvironment and culture conditions during the expansion of cell populations influence shear stress. Cell micro- and macro-structural architectural differences can also affect the efficiency of cellular expansion and product harvest. In March 2025, variation in the performance of a microcarrier system for a cell line exceeding 15% was reported. It is expected that during the next 3-5 years the cell culture industry will depend on integration of advanced and adaptive process and technology controls in order to overcome the limitations in product consistency and reliability for technology and process transfers. • High Costs: There are high costs for validating and commercializing specialized microcarriers. As of July 2025, process validation and testing expenses accounted for more than 20% of total bioprocess development costs, according to an industry survey. Smaller biotechnology companies, especially, postponed or avoided microcarrier purchases and opted for less complex alternatives. Over the next three to five years, the microcarrier industry will likely follow the trend of biopharmaceutical contract services and offer better, standardized products. This is expected to positively impact the microcarrier industry and reduce costs for customers. • Supply and Regulatory Challenges: As of November 2025, the biopharmaceutical contract services industry, which produces specialized polymers and coatings and provides sterile services, faced challenges in supplying single-use bioprocess systems. One industry survey reported average lead times of approximately 12 weeks. Differences in laws and regulations between countries can make it difficult to receive approvals and lead to delays in product distribution. It is likely that in the next 3 to 5 years, disruptions in the supply of microcarriers would continue. To eliminate, or at least minimize, these disruptions, it is likely that manufacturers would need to employ more than one source of supply, manufacture microcarriers locally, and ensure that their suppliers of microcarriers meet the same standards. Demand for microcarriers is expected to increase with the growth of the biomanufacturing industry. Microcarriers offer an ideal platform to support the growth of cells and tissues for use in biomanufacturing and therapies. The microcarrier market will likely benefit from the focus on process and facilities improvement, particularly in biomanufacturing. The market will, however, be limited by the price and supply of biological raw materials. The microcarrier market is likely to be dominated in the near future by a few companies that offer reliable and consistent performance microcarriers at competitive prices. These companies are likely to benefit from the increasing demand for microcarriers by biomanufacturing facilities. List of Disc-Shaped Microcarrier Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies disc-shaped microcarrier market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the disc-shaped microcarrier market companies profiled in this report include- • Eppendorf • SP Bel-Art • LePure Biotech • Shanghai Duoning Biotechnology • Wuhan CEKG Tech Disc-Shaped Microcarrier Market by Segment The study includes a forecast for the global disc-shaped microcarrier market by type, application, and region. Disc-Shaped Microcarrier Market by Type [Value ($M) from 2019 to 2035]: • Double-layer • Triple-layer Disc-Shaped Microcarrier Market by Application [Value ($M) from 2019 to 2035]: • Cell Therapy • Vaccine Production • Others Disc-Shaped Microcarrier Market by Region [Value ($M) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Disc-Shaped Microcarrier Market The market for microcarriers in the form of small discs is forecasted to develop in the direction of large-scale cell expansion in the field of regenerative medicine. The period from 2025 to 2027 is expected to see an improvement in funding for biomedical research, increased capacity for biologics, and the advancement of automation and flexibility in defined cell culture. According to Lucintel’s most recent report, further growth in this period will be a result of the increased investment in the bioprocessing and cell therapy industries. • United States: The investment and expansion of domestic cell manufacturing facilities, as well as the draft guidance on the manufacturing of autologous cell therapies by the FDA, all occurred in 2025. Additionally, Thermo Fisher Scientific announced that it would be expanding its bioprocessing services and facilities in the U.S. The above occurrences are expected to result in increased demand for high-quality microcarriers in the following years. • China: Also in 2025, the Chinese National Medical Products Administration (NMPA) approved 30 innovative biologics, as well as other policy changes. These events are also expected to positively impact the cell therapy and bioprocessing industries, and result in the increased use of high-quality microcarriers in the same period. • Germany: Sartorius reported 2024 bioprocessing solutions revenue of €2.04 billion, with further investments in single-use and cell culture technologies. German equipment and technology integration will likely aid the acceptance of disc-shaped carrier technologies in the pharmaceutical industry. • India: Precision biopharmaceuticals, bio foundries, and other components of the 2024 BioE3 policy are expected to catalyze the local manufacturing of biopharmaceuticals and advance cell-based therapies. With the 2025 Union Budget allocation of ₹100 billion, a larger body of process-development talent and opportunities to advance process and cell-culture technologies is expected. • Japan: Ongoing approvals of the 2014 regenerative medicines policy and the 2025 allocation of ¥100 billion to the semiconductor and biotechnology sectors, will likely further the establishment of domestic cell-processing and other related services. This, in turn, will augment the demand for specialized microcarrier systems. Features of the Global Disc-Shaped Microcarrier Market Market Size Estimates: disc-shaped microcarrier market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: disc-shaped microcarrier market size by type, application, and region in terms of value ($B). Regional Analysis: disc-shaped microcarrier market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the disc-shaped microcarrier market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the disc-shaped microcarrier market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the disc-shaped microcarrier market by type (double-layer and triple-layer), application (cell therapy, vaccine production, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?